Add To Watchlist
Share URL
About The Company
CEO
Mr. Timothy Sawyer
Market Cap
NaN undefined USD
Sector
Healthcare
Website
http://www.teligent.comLast Update
2/22/2024, 12:00:00 PM
Description
Teligent, Inc., formerly Igi Laboratories Inc, is a specialty generic pharmaceutical company.
Read More
Overview
Value
1
Growth
39
Health
53
Management
70
Analyst Opinion
57
Total
44
All Scores Out Of 100
Best Features
- Earnings growth has improved recently
- Has a low level of debt
- Low preportion of income is paid as dividend
Risk Factors
- Overvalued on cashflow basis
- Earnings are negative
- There is a history of diluting shareholders
- Disliked by Twitter users
- Poor earnings and cashflow growth
- Dividend could be at risk
Market Peers
TLGT
Key Figures
PE Ratio (TTM)
N/A
Margin Of Safety (DCF)
N/A
Revenue Growth (5 Year Average)
3.11%
Ratings Consensus
Neutral
Share Buybacks
-18.38%
Dividend Yeild (TTM)
N/A
Valuation
Value Score
1
Desired Margin Of Safety
0%
▼
Tip: Set your desired Margin Of Safety
Free Cash Flow Type
Annual Cashflow Growth
0%
Discount Rate
0%
Buy Target: N/ANaNNaN
Current Price: 0.2 USD
Negative Cashflows: Cashflow can become negative due to operating losses, investing activities or financing activites. Negative cashflow makes it dificult to use a discounted free cashflow model to assess intrinsic value.
How Does This Work?
Show Advanced Options
This calculator helps investors estimate the Intrinsic Value of a company based on the current value of future cash flows. To use the tool, simply input a desired Margin Of Safety, which is an additional discount applied to the present value of the expected future cash flows. The tool calculates the present value using a discount rate that reflects the risk and time value of money, and provides an estimated target price for the company based on the selected margin of safety. The calculator defaults to using 5 Year Free Cash Flow Growth % and a discount rate based on the US 10-year treasury bond coupon rate. Use our performance analyser to get a feel the impact this has on longterm investment returns and discover a margin of safety you are comfortable with. This can be a useful tool for investors looking to make informed decisions about whether to buy or sell shares of a particular company.
Price/Earnings
N/Ax
Free Cashflow Yeild
N/A
PE/Earnings Growth
N/A
Price/Book
Infinityx
Growth
Growth Score
39
- ✔ Earnings growth has improved this year
- ✔ 5 Year Average Cashflow growth of 13.92% is higher than the market average (12.35%)
- ✘ 5 Year Average Revenue growth of 3.11% is lower than the market average (10.97%)
- ✘ Revenue growth has slowed this year
- ✘ 5 Year Average Earnings growth of 4.25% is lower than the market average (14.48%)
- ✘ Free Cashflow growth has slowed this year
Revenue Growth
3.11%
Earnings Growth
4.25%
Cashflow Growth
13.92%
Health
Health Score
53
Altman Z Score
N/A
Piostroski Score
N/A
Debt/Equity
0.00x
Current Assets/Liabilities
4.10x
Free Cashflow/Total Debt
0.00x
Debt/Capital
2.27x
Dividend
Secure Dividend Score
0
- ✔ Long term dividend payout ratio of 0.00% is considered good
- ✔ Payout ratio (TTM) of 0.00% is lower than the average (40%)
- ✔ Dividends have shown growth over the last 5 years
- ✔ Spending a lower percentage of their income on dividends than last 5 years
- ✘ Dividend yeild of N/A is less than the market average (1.85%)
- ✘ Very unsafe
Dividend Yeild
N/A
Dividend Growth
0.00%
Payout Ratio (Earnings)
0.00%
Payout Ratio (Cashflow)
0.00%
Management
Management Score
70
Average Buybacks/Dilution
-18.38%
Recent Buybacks/Dilution
-100.00%
5 Year Price Volitility
94.33%
Return On Assets
0.00%
Return On Capital Employed
-10.97%
Return On Equity
0.00%
Return On Free Cashflow
N/A
Return On Investments
N/A
Analysts
Analyst Opinion
57
- ✔ Ratings consensus is Neutral
SEC Filings
Find yearly (10-K), quaterly (10-Q) and disclosure (8-K) report here, on the Securities and Exchange Commission's EDGAR database. If reading through reports isn't your cup of tea, don't worry. We've made it easy for you by summarizing all the important bits.
Other Information
Company Name
Teligent, Inc.
Currency
USD
Beta
1.617989
Vol Avg
7974305
Ceo
Mr. Timothy Sawyer
Cik
0000352998
Cusip
87960W203
Exchange
Nasdaq Global Select
Full Time Employees
142
Industry
Drug Manufacturers—Specialty & Generic
Sector
Healthcare
Ipo Date
1981-07-30
Address
105 Lincoln Avenue
City
Buena
State
NEW JERSEY
Country
US
Zip
08310
Phone
16096971441
Analysis Last Updated
2/22/2024, 12:00:00 PM
All financial data provided by FMP
Social Sentiment
Social Sentiment Score
0
Twitter Sentiment
N/A
Stocktwits Sentiment
N/A